

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.74955926 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 6.74955926 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.72422791 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.72422791 |
| 5 | lysine metabolic process (GO:0006553) | 6.50915469 |
| 6 | lysine catabolic process (GO:0006554) | 6.50915469 |
| 7 | glyoxylate metabolic process (GO:0046487) | 6.46559114 |
| 8 | cysteine metabolic process (GO:0006534) | 6.27687571 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.24380662 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 6.11681350 |
| 11 | urate metabolic process (GO:0046415) | 5.78476759 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.77910665 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.77910665 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.77910665 |
| 15 | drug transmembrane transport (GO:0006855) | 5.72718943 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.53285369 |
| 17 | serine family amino acid biosynthetic process (GO:0009070) | 5.43362883 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.39759319 |
| 19 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.36038914 |
| 20 | drug transport (GO:0015893) | 5.17388464 |
| 21 | serine family amino acid metabolic process (GO:0009069) | 5.17125807 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.09449276 |
| 23 | aspartate family amino acid catabolic process (GO:0009068) | 5.05607288 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.02251602 |
| 25 | phospholipid efflux (GO:0033700) | 4.97913830 |
| 26 | NADH metabolic process (GO:0006734) | 4.81810330 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.76733915 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.72434543 |
| 29 | plasma lipoprotein particle assembly (GO:0034377) | 4.71582450 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.60264860 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.59591863 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.56484324 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.55735362 |
| 34 | glycine metabolic process (GO:0006544) | 4.52936488 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.52096995 |
| 36 | short-chain fatty acid metabolic process (GO:0046459) | 4.44230675 |
| 37 | bile acid biosynthetic process (GO:0006699) | 4.43674919 |
| 38 | alpha-amino acid catabolic process (GO:1901606) | 4.43534154 |
| 39 | omega-hydroxylase P450 pathway (GO:0097267) | 4.41706415 |
| 40 | cellular modified amino acid catabolic process (GO:0042219) | 4.41439331 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.38739340 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.38739340 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.38739340 |
| 44 | proline metabolic process (GO:0006560) | 4.34773734 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.34177350 |
| 46 | cellular amino acid catabolic process (GO:0009063) | 4.31292799 |
| 47 | acetyl-CoA metabolic process (GO:0006084) | 4.29651851 |
| 48 | complement activation, alternative pathway (GO:0006957) | 4.29351320 |
| 49 | glutamate metabolic process (GO:0006536) | 4.28529779 |
| 50 | drug catabolic process (GO:0042737) | 4.27985976 |
| 51 | regulation of complement activation (GO:0030449) | 4.24886112 |
| 52 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.23959004 |
| 53 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.23959004 |
| 54 | response to mercury ion (GO:0046689) | 4.22321788 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 4.20783947 |
| 56 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.19452084 |
| 57 | cholesterol efflux (GO:0033344) | 4.18755665 |
| 58 | protein-lipid complex assembly (GO:0065005) | 4.15812529 |
| 59 | L-serine metabolic process (GO:0006563) | 4.13702223 |
| 60 | oxaloacetate metabolic process (GO:0006107) | 4.11978782 |
| 61 | intestinal absorption (GO:0050892) | 4.11110318 |
| 62 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09132449 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.06838051 |
| 64 | amine catabolic process (GO:0009310) | 4.06838051 |
| 65 | branched-chain amino acid metabolic process (GO:0009081) | 4.04619460 |
| 66 | organic cation transport (GO:0015695) | 4.03777849 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.03270717 |
| 68 | aldehyde catabolic process (GO:0046185) | 4.02798784 |
| 69 | arginine metabolic process (GO:0006525) | 4.01417630 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 4.00170636 |
| 71 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.96796423 |
| 72 | branched-chain amino acid catabolic process (GO:0009083) | 3.95317955 |
| 73 | intestinal cholesterol absorption (GO:0030299) | 3.95280924 |
| 74 | fibrinolysis (GO:0042730) | 3.94320637 |
| 75 | valine metabolic process (GO:0006573) | 3.94124582 |
| 76 | proline biosynthetic process (GO:0006561) | 3.88355277 |
| 77 | heme transport (GO:0015886) | 3.87456713 |
| 78 | reverse cholesterol transport (GO:0043691) | 3.87026692 |
| 79 | phosphate ion transport (GO:0006817) | 3.86278428 |
| 80 | fatty acid beta-oxidation (GO:0006635) | 3.85988927 |
| 81 | angiotensin maturation (GO:0002003) | 3.83511034 |
| 82 | carnitine metabolic process (GO:0009437) | 3.81813584 |
| 83 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.81137143 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.80712408 |
| 85 | organic acid catabolic process (GO:0016054) | 3.80712408 |
| 86 | bile acid metabolic process (GO:0008206) | 3.78920738 |
| 87 | phosphate ion transmembrane transport (GO:0035435) | 3.76491192 |
| 88 | ketone body metabolic process (GO:1902224) | 3.73013221 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 3.72151645 |
| 90 | plasma lipoprotein particle organization (GO:0071827) | 3.71427962 |
| 91 | fatty acid oxidation (GO:0019395) | 3.70517353 |
| 92 | urea metabolic process (GO:0019627) | 3.69675873 |
| 93 | urea cycle (GO:0000050) | 3.69675873 |
| 94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.69438942 |
| 95 | acylglycerol homeostasis (GO:0055090) | 3.68133761 |
| 96 | triglyceride homeostasis (GO:0070328) | 3.68133761 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.67495621 |
| 98 | tricarboxylic acid metabolic process (GO:0072350) | 3.66067865 |
| 99 | phenylpropanoid metabolic process (GO:0009698) | 3.65453801 |
| 100 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.64938659 |
| 101 | ethanol oxidation (GO:0006069) | 3.63984496 |
| 102 | lipid oxidation (GO:0034440) | 3.63760937 |
| 103 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.62406082 |
| 104 | alkaloid metabolic process (GO:0009820) | 3.61699315 |
| 105 | ethanol metabolic process (GO:0006067) | 3.61222676 |
| 106 | nitrogen cycle metabolic process (GO:0071941) | 3.59745178 |
| 107 | tyrosine metabolic process (GO:0006570) | 3.58642965 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.57158152 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.56451048 |
| 110 | hormone catabolic process (GO:0042447) | 3.54567559 |
| 111 | coenzyme catabolic process (GO:0009109) | 3.53669428 |
| 112 | oxidative demethylation (GO:0070989) | 3.53092178 |
| 113 | fatty acid catabolic process (GO:0009062) | 3.52146148 |
| 114 | plasma lipoprotein particle clearance (GO:0034381) | 3.51795555 |
| 115 | glutathione biosynthetic process (GO:0006750) | 3.50797718 |
| 116 | regulation of plasminogen activation (GO:0010755) | 3.50053961 |
| 117 | protein-lipid complex subunit organization (GO:0071825) | 3.47077974 |
| 118 | drug metabolic process (GO:0017144) | 3.46776479 |
| 119 | cellular glucuronidation (GO:0052695) | 3.46697605 |
| 120 | very long-chain fatty acid metabolic process (GO:0000038) | 3.45682023 |
| 121 | monocarboxylic acid catabolic process (GO:0072329) | 3.45336842 |
| 122 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.43379493 |
| 123 | negative regulation of hemostasis (GO:1900047) | 3.43186868 |
| 124 | negative regulation of blood coagulation (GO:0030195) | 3.43186868 |
| 125 | regulation of cholesterol esterification (GO:0010872) | 3.42929334 |
| 126 | negative regulation of cholesterol transport (GO:0032375) | 3.41554843 |
| 127 | negative regulation of sterol transport (GO:0032372) | 3.41554843 |
| 128 | lipoprotein metabolic process (GO:0042157) | 3.41295508 |
| 129 | cholesterol homeostasis (GO:0042632) | 3.38897776 |
| 130 | sulfur amino acid metabolic process (GO:0000096) | 3.38227385 |
| 131 | L-ascorbic acid metabolic process (GO:0019852) | 3.37978159 |
| 132 | dicarboxylic acid metabolic process (GO:0043648) | 3.36883707 |
| 133 | flavonoid metabolic process (GO:0009812) | 3.33091433 |
| 134 | sterol homeostasis (GO:0055092) | 3.32614184 |
| 135 | quaternary ammonium group transport (GO:0015697) | 3.30595192 |
| 136 | response to phenylpropanoid (GO:0080184) | 3.30531510 |
| 137 | glutathione derivative biosynthetic process (GO:1901687) | 3.29037853 |
| 138 | glutathione derivative metabolic process (GO:1901685) | 3.29037853 |
| 139 | small molecule catabolic process (GO:0044282) | 3.28298689 |
| 140 | high-density lipoprotein particle remodeling (GO:0034375) | 3.28137094 |
| 141 | aspartate family amino acid metabolic process (GO:0009066) | 3.24393022 |
| 142 | glucuronate metabolic process (GO:0019585) | 3.23650890 |
| 143 | uronic acid metabolic process (GO:0006063) | 3.23650890 |
| 144 | negative regulation of coagulation (GO:0050819) | 3.21767190 |
| 145 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.20055116 |
| 146 | fructose metabolic process (GO:0006000) | 3.19942184 |
| 147 | acyl-CoA metabolic process (GO:0006637) | 3.18811828 |
| 148 | thioester metabolic process (GO:0035383) | 3.18811828 |
| 149 | positive regulation of lipid catabolic process (GO:0050996) | 3.18312335 |
| 150 | protein carboxylation (GO:0018214) | 3.15820322 |
| 151 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.15820322 |
| 152 | vitamin biosynthetic process (GO:0009110) | 3.15134827 |
| 153 | regulation of triglyceride catabolic process (GO:0010896) | 3.13673892 |
| 154 | glutathione metabolic process (GO:0006749) | 3.13331939 |
| 155 | low-density lipoprotein particle remodeling (GO:0034374) | 3.10151428 |
| 156 | doxorubicin metabolic process (GO:0044598) | 3.08497128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.89906444 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.58403660 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.92108148 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.18655550 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.15663123 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97237906 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.67638858 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.49307799 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.91430806 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.78004469 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.45036399 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.37355594 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.34649362 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.24164346 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.12619928 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.96500948 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.95510810 |
| 18 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.95060067 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.93756062 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.93671678 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.93071413 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88150734 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.86672663 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77411144 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.73497516 |
| 26 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.68882993 |
| 27 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.64080212 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61764420 |
| 29 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.53163211 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50907064 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.50720042 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50602297 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.48876744 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.45646468 |
| 35 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39905482 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.39455148 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33494508 |
| 38 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32425451 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.31640050 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30935878 |
| 41 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.30141778 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29794272 |
| 43 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28338609 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.27618606 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27397397 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27254075 |
| 47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23257829 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22552650 |
| 49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19206576 |
| 50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18283073 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.16171927 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15177765 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15072567 |
| 54 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.14295503 |
| 55 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.13952369 |
| 56 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11105793 |
| 57 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10288086 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10197877 |
| 59 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09670936 |
| 60 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07705801 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.07397232 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07183042 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06791711 |
| 64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.05897969 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.05734040 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05729841 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04224434 |
| 68 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02034382 |
| 69 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01273477 |
| 70 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99930110 |
| 71 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99607196 |
| 72 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99095189 |
| 73 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.95297903 |
| 74 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94704613 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94085577 |
| 76 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93681968 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92780198 |
| 78 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92686288 |
| 79 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.92094833 |
| 80 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91557045 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90903927 |
| 82 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.89838045 |
| 83 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89367825 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88689972 |
| 85 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87530661 |
| 86 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87210806 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86799218 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.86503569 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86448847 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86427982 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86284516 |
| 92 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.86078603 |
| 93 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.85774406 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85519765 |
| 95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.84976924 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.84672182 |
| 97 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.84570728 |
| 98 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.84264379 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84024798 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83407848 |
| 101 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83158557 |
| 102 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.82974964 |
| 103 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.82949667 |
| 104 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82460240 |
| 105 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.82426236 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81721836 |
| 107 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81410616 |
| 108 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81351927 |
| 109 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.81117362 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80894706 |
| 111 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.80140716 |
| 112 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.79810708 |
| 113 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.79586093 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77961704 |
| 115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.77602085 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77092262 |
| 117 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76361552 |
| 118 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.75850988 |
| 119 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.75668856 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.74475999 |
| 121 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.74302189 |
| 122 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.72768046 |
| 123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.72341669 |
| 124 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.72292484 |
| 125 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.72287727 |
| 126 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71877080 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.71655965 |
| 128 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.71573233 |
| 129 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71246647 |
| 130 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.71136977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.50530326 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.65438884 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 5.03837884 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.68814323 |
| 5 | MP0005365_abnormal_bile_salt | 4.54103902 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.32060077 |
| 7 | MP0005332_abnormal_amino_acid | 4.03153067 |
| 8 | MP0003195_calcinosis | 3.33714587 |
| 9 | MP0004043_abnormal_pH_regulation | 3.25460615 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 3.24355353 |
| 11 | MP0003252_abnormal_bile_duct | 2.92837062 |
| 12 | MP0009840_abnormal_foam_cell | 2.85964549 |
| 13 | MP0009643_abnormal_urine_homeostasis | 2.56349081 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.46090817 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.38855633 |
| 16 | MP0003186_abnormal_redox_activity | 2.21376186 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.02857321 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.95601974 |
| 19 | MP0005636_abnormal_mineral_homeostasis | 1.88544806 |
| 20 | MP0001764_abnormal_homeostasis | 1.88438324 |
| 21 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.81084460 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.79612465 |
| 23 | MP0005083_abnormal_biliary_tract | 1.75159082 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 1.70080337 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.67925846 |
| 26 | MP0000609_abnormal_liver_physiology | 1.64061167 |
| 27 | MP0005451_abnormal_body_composition | 1.59388292 |
| 28 | MP0001756_abnormal_urination | 1.56838684 |
| 29 | MP0002136_abnormal_kidney_physiology | 1.46830278 |
| 30 | MP0001765_abnormal_ion_homeostasis | 1.38764905 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.37451373 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.20512316 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.19903500 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.16076693 |
| 35 | MP0003878_abnormal_ear_physiology | 1.11775716 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 1.11775716 |
| 37 | MP0004147_increased_porphyrin_level | 1.10518881 |
| 38 | MP0000598_abnormal_liver_morphology | 1.09445687 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.05742238 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.04371596 |
| 41 | MP0003868_abnormal_feces_composition | 1.02042310 |
| 42 | MP0005266_abnormal_metabolism | 0.92941079 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 0.92296652 |
| 44 | MP0003718_maternal_effect | 0.92052951 |
| 45 | MP0002132_abnormal_respiratory_system | 0.91065152 |
| 46 | MP0001661_extended_life_span | 0.89264624 |
| 47 | MP0005376_homeostasis/metabolism_phenot | 0.86332126 |
| 48 | MP0009379_abnormal_foot_pigmentation | 0.86197310 |
| 49 | MP0003638_abnormal_response/metabolism_ | 0.86011689 |
| 50 | MP0009642_abnormal_blood_homeostasis | 0.84947828 |
| 51 | MP0008469_abnormal_protein_level | 0.83723652 |
| 52 | MP0002876_abnormal_thyroid_physiology | 0.82979684 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 0.82654445 |
| 54 | MP0009765_abnormal_xenobiotic_induced | 0.82154553 |
| 55 | MP0000604_amyloidosis | 0.81936491 |
| 56 | MP0003693_abnormal_embryo_hatching | 0.81313564 |
| 57 | MP0003011_delayed_dark_adaptation | 0.75707935 |
| 58 | MP0009763_increased_sensitivity_to | 0.75233232 |
| 59 | MP0003879_abnormal_hair_cell | 0.73938067 |
| 60 | MP0003329_amyloid_beta_deposits | 0.72573844 |
| 61 | MP0003690_abnormal_glial_cell | 0.71624533 |
| 62 | MP0000678_abnormal_parathyroid_gland | 0.69035397 |
| 63 | MP0000920_abnormal_myelination | 0.68791283 |
| 64 | MP0009697_abnormal_copulation | 0.66848467 |
| 65 | MP0010155_abnormal_intestine_physiology | 0.66597080 |
| 66 | MP0005670_abnormal_white_adipose | 0.66419667 |
| 67 | MP0000538_abnormal_urinary_bladder | 0.65734574 |
| 68 | MP0008873_increased_physiological_sensi | 0.64255630 |
| 69 | MP0005408_hypopigmentation | 0.64135314 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 0.62655929 |
| 71 | MP0003941_abnormal_skin_development | 0.62603231 |
| 72 | MP0005395_other_phenotype | 0.61784616 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 0.60107974 |
| 74 | MP0005448_abnormal_energy_balance | 0.59615922 |
| 75 | MP0004885_abnormal_endolymph | 0.57025641 |
| 76 | MP0002135_abnormal_kidney_morphology | 0.56650598 |
| 77 | MP0004858_abnormal_nervous_system | 0.56423500 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 0.55567874 |
| 79 | MP0009764_decreased_sensitivity_to | 0.54632375 |
| 80 | MP0005501_abnormal_skin_physiology | 0.54309827 |
| 81 | MP0001881_abnormal_mammary_gland | 0.53376368 |
| 82 | MP0005647_abnormal_sex_gland | 0.53339321 |
| 83 | MP0005535_abnormal_body_temperature | 0.52577936 |
| 84 | MP0005166_decreased_susceptibility_to | 0.51862314 |
| 85 | MP0004133_heterotaxia | 0.51745722 |
| 86 | MP0009115_abnormal_fat_cell | 0.51547328 |
| 87 | MP0001664_abnormal_digestion | 0.51304559 |
| 88 | MP0002796_impaired_skin_barrier | 0.51242905 |
| 89 | MP0000566_synostosis | 0.50181029 |
| 90 | MP0005334_abnormal_fat_pad | 0.49247508 |
| 91 | MP0005330_cardiomyopathy | 0.49166627 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.47903408 |
| 93 | MP0003315_abnormal_perineum_morphology | 0.47776895 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.47260439 |
| 95 | MP0002970_abnormal_white_adipose | 0.46918418 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.46622891 |
| 97 | MP0004957_abnormal_blastocyst_morpholog | 0.45714375 |
| 98 | MP0004142_abnormal_muscle_tone | 0.45117295 |
| 99 | MP0009053_abnormal_anal_canal | 0.45034921 |
| 100 | MP0009672_abnormal_birth_weight | 0.44120932 |
| 101 | MP0006082_CNS_inflammation | 0.42726223 |
| 102 | MP0000490_abnormal_crypts_of | 0.42626103 |
| 103 | MP0003172_abnormal_lysosome_physiology | 0.42466147 |
| 104 | MP0002938_white_spotting | 0.41872718 |
| 105 | MP0000371_diluted_coat_color | 0.39260261 |
| 106 | MP0000747_muscle_weakness | 0.39213566 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.39047490 |
| 108 | MP0004272_abnormal_basement_membrane | 0.38474487 |
| 109 | MP0000467_abnormal_esophagus_morphology | 0.37539877 |
| 110 | MP0001663_abnormal_digestive_system | 0.37075641 |
| 111 | MP0001873_stomach_inflammation | 0.36827946 |
| 112 | MP0005023_abnormal_wound_healing | 0.36625060 |
| 113 | MP0002254_reproductive_system_inflammat | 0.36184469 |
| 114 | MP0001730_embryonic_growth_arrest | 0.33911557 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.33402421 |
| 116 | MP0001958_emphysema | 0.33368006 |
| 117 | MP0002396_abnormal_hematopoietic_system | 0.32992401 |
| 118 | MP0003075_altered_response_to | 0.32719677 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.30068442 |
| 120 | MP0000358_abnormal_cell_content/ | 0.29876229 |
| 121 | MP0003724_increased_susceptibility_to | 0.29677210 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.29656578 |
| 123 | MP0008872_abnormal_physiological_respon | 0.28402971 |
| 124 | MP0002971_abnormal_brown_adipose | 0.27643829 |
| 125 | MP0001293_anophthalmia | 0.27191931 |
| 126 | MP0002168_other_aberrant_phenotype | 0.26817732 |
| 127 | MP0000477_abnormal_intestine_morphology | 0.26577054 |
| 128 | MP0002269_muscular_atrophy | 0.26485130 |
| 129 | MP0003953_abnormal_hormone_level | 0.26155056 |
| 130 | MP0010094_abnormal_chromosome_stability | 0.25231405 |
| 131 | MP0003959_abnormal_lean_body | 0.24491972 |
| 132 | MP0000462_abnormal_digestive_system | 0.24008595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.67884141 |
| 2 | Hyperglycinuria (HP:0003108) | 5.28457467 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.99432006 |
| 4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.96706019 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 4.96706019 |
| 6 | Gout (HP:0001997) | 4.75512099 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.65741841 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.59248915 |
| 9 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.37853834 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.32585630 |
| 11 | Ketosis (HP:0001946) | 4.30525646 |
| 12 | Hyperammonemia (HP:0001987) | 4.23148984 |
| 13 | Xanthomatosis (HP:0000991) | 4.05525741 |
| 14 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.03462168 |
| 15 | Abnormality of complement system (HP:0005339) | 3.99299306 |
| 16 | Hyperglycinemia (HP:0002154) | 3.97438488 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.97352940 |
| 18 | Proximal tubulopathy (HP:0000114) | 3.83968188 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 3.83891791 |
| 20 | Ketoacidosis (HP:0001993) | 3.79274927 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 3.72356914 |
| 22 | Metabolic alkalosis (HP:0200114) | 3.71644027 |
| 23 | Hypomagnesemia (HP:0002917) | 3.69037561 |
| 24 | Increased circulating renin level (HP:0000848) | 3.66000353 |
| 25 | Hypokalemic alkalosis (HP:0001949) | 3.64440291 |
| 26 | Deep venous thrombosis (HP:0002625) | 3.59988355 |
| 27 | Abnormality of nucleobase metabolism (HP:0010932) | 3.55566626 |
| 28 | Increased purine levels (HP:0004368) | 3.55471175 |
| 29 | Hyperuricemia (HP:0002149) | 3.55471175 |
| 30 | Generalized aminoaciduria (HP:0002909) | 3.45779007 |
| 31 | Glomerulonephritis (HP:0000099) | 3.38101917 |
| 32 | Alkalosis (HP:0001948) | 3.36449498 |
| 33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.33056946 |
| 34 | Dicarboxylic aciduria (HP:0003215) | 3.33056946 |
| 35 | Abnormal urine output (HP:0012590) | 3.32860966 |
| 36 | Polyuria (HP:0000103) | 3.23485152 |
| 37 | Prolonged partial thromboplastin time (HP:0003645) | 3.22158867 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21986049 |
| 39 | Abnormality of magnesium homeostasis (HP:0004921) | 3.19694146 |
| 40 | Hyperactive renin-angiotensin system (HP:0000841) | 3.18247813 |
| 41 | Abnormality of urine glucose concentration (HP:0011016) | 3.17285130 |
| 42 | Glycosuria (HP:0003076) | 3.17285130 |
| 43 | Abnormality of methionine metabolism (HP:0010901) | 3.13651044 |
| 44 | Lethargy (HP:0001254) | 3.11704135 |
| 45 | Metabolic acidosis (HP:0001942) | 3.06840634 |
| 46 | Hyperlipoproteinemia (HP:0010980) | 3.02414787 |
| 47 | Abnormality of renal excretion (HP:0011036) | 3.00822809 |
| 48 | Abnormality of chloride homeostasis (HP:0011422) | 2.94466722 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.93519886 |
| 50 | Spontaneous abortion (HP:0005268) | 2.90837035 |
| 51 | Abnormal gallbladder physiology (HP:0012438) | 2.89950690 |
| 52 | Cholecystitis (HP:0001082) | 2.89950690 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.88308914 |
| 54 | Fat malabsorption (HP:0002630) | 2.87094207 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.82341196 |
| 56 | Cerebral edema (HP:0002181) | 2.78000142 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.77543995 |
| 58 | Hemorrhage of the eye (HP:0011885) | 2.73895973 |
| 59 | Vomiting (HP:0002013) | 2.72064461 |
| 60 | Joint hemorrhage (HP:0005261) | 2.69616777 |
| 61 | * Delayed CNS myelination (HP:0002188) | 2.69061045 |
| 62 | Malnutrition (HP:0004395) | 2.63994244 |
| 63 | Vascular calcification (HP:0004934) | 2.62753474 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.62513806 |
| 65 | Increased serum pyruvate (HP:0003542) | 2.62513806 |
| 66 | Ileus (HP:0002595) | 2.59794515 |
| 67 | Abnormality of vitamin metabolism (HP:0100508) | 2.59607516 |
| 68 | Hyperphosphaturia (HP:0003109) | 2.59271696 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.57652762 |
| 70 | Renal salt wasting (HP:0000127) | 2.57487075 |
| 71 | Hyperbilirubinemia (HP:0002904) | 2.56686213 |
| 72 | Hypoalphalipoproteinemia (HP:0003233) | 2.52452506 |
| 73 | Irritability (HP:0000737) | 2.50819593 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.49355537 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.49355537 |
| 76 | Spastic diplegia (HP:0001264) | 2.49093006 |
| 77 | Acanthocytosis (HP:0001927) | 2.48325496 |
| 78 | Polydipsia (HP:0001959) | 2.47561529 |
| 79 | Abnormal drinking behavior (HP:0030082) | 2.47561529 |
| 80 | Opisthotonus (HP:0002179) | 2.43097738 |
| 81 | Cerebral palsy (HP:0100021) | 2.40531236 |
| 82 | Confusion (HP:0001289) | 2.40200061 |
| 83 | Abnormality of the intrinsic pathway (HP:0010989) | 2.38840541 |
| 84 | Nephritis (HP:0000123) | 2.38481348 |
| 85 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.38074079 |
| 86 | Abnormal urine phosphate concentration (HP:0012599) | 2.36433663 |
| 87 | Rickets (HP:0002748) | 2.32570502 |
| 88 | Hepatic necrosis (HP:0002605) | 2.32074791 |
| 89 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.31775161 |
| 90 | Methylmalonic aciduria (HP:0012120) | 2.30946874 |
| 91 | Nephrolithiasis (HP:0000787) | 2.26934960 |
| 92 | Megaloblastic anemia (HP:0001889) | 2.25482195 |
| 93 | Steatorrhea (HP:0002570) | 2.24313859 |
| 94 | Renal tubular acidosis (HP:0001947) | 2.23935872 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.23010380 |
| 96 | Nausea (HP:0002018) | 2.22086553 |
| 97 | Epidermoid cyst (HP:0200040) | 2.20798057 |
| 98 | Tetany (HP:0001281) | 2.20440093 |
| 99 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.18633497 |
| 100 | Abnormality of the common coagulation pathway (HP:0010990) | 2.17766229 |
| 101 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.16917230 |
| 102 | Hyperaldosteronism (HP:0000859) | 2.12645449 |
| 103 | Cholelithiasis (HP:0001081) | 2.07224077 |
| 104 | Enlarged kidneys (HP:0000105) | 2.06347568 |
| 105 | Hypercholesterolemia (HP:0003124) | 2.05082429 |
| 106 | Widely patent fontanelles and sutures (HP:0004492) | 2.04496317 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 2.04446824 |
| 108 | Late onset (HP:0003584) | 2.04043341 |
| 109 | Abnormality of vitamin B metabolism (HP:0004340) | 2.03507846 |
| 110 | Abnormality of renin-angiotensin system (HP:0000847) | 2.02026381 |
| 111 | Spastic paraparesis (HP:0002313) | 2.01589416 |
| 112 | Hypophosphatemic rickets (HP:0004912) | 1.99728849 |
| 113 | Hepatocellular necrosis (HP:0001404) | 1.98650505 |
| 114 | Conjugated hyperbilirubinemia (HP:0002908) | 1.96964388 |
| 115 | Hypercalciuria (HP:0002150) | 1.96476590 |
| 116 | Neonatal onset (HP:0003623) | 1.95450833 |
| 117 | Elevated alkaline phosphatase (HP:0003155) | 1.94027217 |
| 118 | Abnormal gallbladder morphology (HP:0012437) | 1.93194828 |
| 119 | * Acute encephalopathy (HP:0006846) | 1.91667548 |
| 120 | Complement deficiency (HP:0004431) | 1.91358654 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 1.91331287 |
| 122 | Renal tubular dysfunction (HP:0000124) | 1.90486249 |
| 123 | Abnormal tarsal ossification (HP:0008369) | 1.89264198 |
| 124 | Rhabdomyolysis (HP:0003201) | 1.88979517 |
| 125 | Hypophosphatemia (HP:0002148) | 1.87458842 |
| 126 | Type I transferrin isoform profile (HP:0003642) | 1.82562317 |
| 127 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.82103703 |
| 128 | CNS demyelination (HP:0007305) | 1.81162103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.54595434 |
| 2 | WNK3 | 5.36935829 |
| 3 | OXSR1 | 5.01359645 |
| 4 | WNK4 | 4.91880444 |
| 5 | EPHA2 | 3.33321271 |
| 6 | VRK2 | 3.14567665 |
| 7 | STK39 | 2.69534796 |
| 8 | NEK1 | 2.28663745 |
| 9 | STK16 | 1.98956321 |
| 10 | MAPKAPK3 | 1.97368999 |
| 11 | EPHB1 | 1.94554637 |
| 12 | ERN1 | 1.91813790 |
| 13 | PBK | 1.83770301 |
| 14 | TESK2 | 1.81447101 |
| 15 | BUB1 | 1.77788842 |
| 16 | NME1 | 1.75462666 |
| 17 | MET | 1.66406454 |
| 18 | NME2 | 1.63241986 |
| 19 | MAP3K12 | 1.59894071 |
| 20 | WEE1 | 1.57839608 |
| 21 | SMG1 | 1.54370428 |
| 22 | RIPK1 | 1.52086312 |
| 23 | GRK6 | 1.50263346 |
| 24 | FGFR4 | 1.48154645 |
| 25 | AKT3 | 1.46241425 |
| 26 | FLT3 | 1.41432205 |
| 27 | PINK1 | 1.41309369 |
| 28 | PRKG2 | 1.41048153 |
| 29 | EIF2AK1 | 1.40569198 |
| 30 | MAPK11 | 1.36082356 |
| 31 | LMTK2 | 1.34379574 |
| 32 | MUSK | 1.34344164 |
| 33 | MST4 | 1.26912989 |
| 34 | INSRR | 1.22710301 |
| 35 | ABL2 | 1.20429397 |
| 36 | EIF2AK3 | 1.20051204 |
| 37 | SIK1 | 1.12091149 |
| 38 | STK10 | 1.11647956 |
| 39 | MAP3K11 | 1.11477513 |
| 40 | LRRK2 | 1.08100909 |
| 41 | EEF2K | 1.08005772 |
| 42 | MST1R | 1.00545437 |
| 43 | TTK | 0.96948077 |
| 44 | MAP3K8 | 0.96851433 |
| 45 | ICK | 0.94288060 |
| 46 | TLK1 | 0.94049105 |
| 47 | MYLK | 0.92405878 |
| 48 | DAPK1 | 0.90132356 |
| 49 | MAP2K2 | 0.89909395 |
| 50 | MAP3K2 | 0.89714398 |
| 51 | TESK1 | 0.88688888 |
| 52 | PDK3 | 0.88245362 |
| 53 | PDK4 | 0.88245362 |
| 54 | PIM2 | 0.87047824 |
| 55 | MAP3K3 | 0.86944961 |
| 56 | PAK4 | 0.84312328 |
| 57 | MAPK15 | 0.84138549 |
| 58 | KDR | 0.82730819 |
| 59 | ARAF | 0.80879291 |
| 60 | FER | 0.78695245 |
| 61 | ILK | 0.77480119 |
| 62 | ACVR1B | 0.77151291 |
| 63 | GSK3A | 0.76521008 |
| 64 | STK38L | 0.76137479 |
| 65 | CDK7 | 0.72946475 |
| 66 | ERBB4 | 0.69294188 |
| 67 | CSF1R | 0.68244259 |
| 68 | MAP2K3 | 0.68148964 |
| 69 | SGK223 | 0.66368780 |
| 70 | SGK494 | 0.66368780 |
| 71 | SCYL2 | 0.65191043 |
| 72 | DYRK3 | 0.65029196 |
| 73 | PDK2 | 0.65008198 |
| 74 | TBK1 | 0.64703273 |
| 75 | WNK1 | 0.64231048 |
| 76 | GRK1 | 0.62560357 |
| 77 | STK4 | 0.62163920 |
| 78 | VRK1 | 0.61780044 |
| 79 | MAP4K1 | 0.61298526 |
| 80 | AURKA | 0.61297049 |
| 81 | MAP2K6 | 0.61143583 |
| 82 | PRKCI | 0.60128290 |
| 83 | DAPK3 | 0.59364737 |
| 84 | ZAK | 0.59046279 |
| 85 | PIK3CA | 0.58672033 |
| 86 | BRSK2 | 0.57882374 |
| 87 | RPS6KB2 | 0.56595720 |
| 88 | CSNK1G3 | 0.55794410 |
| 89 | MATK | 0.55232852 |
| 90 | CDC7 | 0.54715712 |
| 91 | DYRK1B | 0.53269255 |
| 92 | PIM1 | 0.53095225 |
| 93 | NUAK1 | 0.53003620 |
| 94 | MAPK4 | 0.52125838 |
| 95 | CSNK1G1 | 0.51425915 |
| 96 | PKN2 | 0.50840851 |
| 97 | BRSK1 | 0.50764572 |
| 98 | KIT | 0.50018708 |
| 99 | MAPKAPK5 | 0.49987151 |
| 100 | TYK2 | 0.49242756 |
| 101 | CSK | 0.48094711 |
| 102 | CDK4 | 0.47653129 |
| 103 | AKT2 | 0.47407356 |
| 104 | BRAF | 0.43973964 |
| 105 | BTK | 0.43029878 |
| 106 | CSNK2A2 | 0.41997034 |
| 107 | PLK1 | 0.41811775 |
| 108 | CAMK2G | 0.40938004 |
| 109 | PIK3CG | 0.40221035 |
| 110 | CDK8 | 0.39572885 |
| 111 | ERBB2 | 0.39402930 |
| 112 | TRIB3 | 0.38920855 |
| 113 | PTK6 | 0.38332025 |
| 114 | MAP3K1 | 0.37388947 |
| 115 | MAP3K10 | 0.37319577 |
| 116 | BMX | 0.35304977 |
| 117 | PRKACG | 0.33864506 |
| 118 | CSNK2A1 | 0.33682698 |
| 119 | IRAK3 | 0.33654437 |
| 120 | SRPK1 | 0.33175155 |
| 121 | CSNK1A1 | 0.32028608 |
| 122 | AURKB | 0.31124660 |
| 123 | PRKCD | 0.30881993 |
| 124 | PAK1 | 0.30799069 |
| 125 | MKNK1 | 0.30589157 |
| 126 | PRKAA2 | 0.30426741 |
| 127 | PTK2 | 0.29190666 |
| 128 | PRKCA | 0.29024566 |
| 129 | CLK1 | 0.29001839 |
| 130 | PDPK1 | 0.28878710 |
| 131 | MTOR | 0.27102964 |
| 132 | PRKAA1 | 0.25236444 |
| 133 | JAK2 | 0.25167242 |
| 134 | CSNK1E | 0.25012902 |
| 135 | TSSK6 | 0.24516829 |
| 136 | ATR | 0.23674526 |
| 137 | NEK2 | 0.23656982 |
| 138 | TAOK2 | 0.23612082 |
| 139 | UHMK1 | 0.23028354 |
| 140 | IGF1R | 0.22786514 |
| 141 | CSNK1A1L | 0.22586043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08137800 |
| 2 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.02326537 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.78135136 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.76695721 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.72756345 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.64228334 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.57837573 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.54511358 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45430755 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.44735926 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42795693 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.38257586 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33187488 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31624038 |
| 15 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.30172122 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.28599448 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.15420128 |
| 18 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 1.89736998 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.88094109 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81515156 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80194219 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.75139192 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74109448 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71400505 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.63359190 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63255947 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61676715 |
| 28 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.61165012 |
| 29 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.59168259 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.58017340 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57806431 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.54827643 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52515554 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52034069 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47614231 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46896685 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46351885 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43875167 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.43470983 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.43333502 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40645842 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38061515 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.35857195 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32799463 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.32290619 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.31323123 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20469498 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20312206 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16798004 |
| 50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15341347 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11852649 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11484348 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08181332 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03477882 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99547421 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98517470 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.96083734 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95073745 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90495338 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89043941 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84178579 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80223908 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.75057925 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71622920 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70777248 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70347014 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.67408833 |
| 68 | DNA replication_Homo sapiens_hsa03030 | 0.65956375 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55508079 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53394143 |
| 71 | Mismatch repair_Homo sapiens_hsa03430 | 0.46911014 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46559539 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45187516 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42723710 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42613657 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41937191 |
| 77 | Proteasome_Homo sapiens_hsa03050 | 0.38776100 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32697428 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31023213 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30361438 |
| 81 | Ribosome_Homo sapiens_hsa03010 | 0.29965950 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.29386559 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29198906 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28123912 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27867489 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27035106 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26841741 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26719378 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.26477554 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24840341 |
| 91 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.20786949 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20540547 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20299434 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.20005924 |
| 95 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.19646316 |
| 96 | RNA polymerase_Homo sapiens_hsa03020 | 0.19496854 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.16904469 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16602306 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.16546132 |
| 100 | Homologous recombination_Homo sapiens_hsa03440 | 0.13029501 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.12780793 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12065012 |
| 103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.10329230 |
| 104 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.08706755 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08624783 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.07619953 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.05598060 |

